Biopharm Executives Point to Better CMO Performance

Better process control and increased adoption of single-use systems played a part in improving downstream manufacturing

Author Image

By: Eric Langer

President and Managing Partner, BioPlan Associates

Bioprocessing efficiency continues to improve, finds BioPlan Associates in its newly-released 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production.1 Results suggest that biomanufacturers are prioritizing manufacturing efficiency and using a number of different ways to boost productivity. This year, we asked global respondents to identify the single most important trend or operational area that the industry must focus on. By a clear margin, the priority was ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters